StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NASDAQ · KIDS·Healthcare

OrthoPediatrics Corp. Stock Analysis & AI Score

OrthoPediatrics Corp. (KIDS) has an ST Score of 59.1 (B-), driven by its Valuation (A-) and held back by its Growth (C). Analysts rate it Buy with a $25.25 price target (+11.5% upside).

Market Closed
$22.64
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
59
ST Score
59.1/100B-

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryMedical - Devices
IPO Date—
Website—
Country—
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

KIDS
59.1out of 100
Grade B-

OrthoPediatrics Corp. (KIDS) has an ST Score of 59.1 (B-), driven by its Valuation (A-) and held back by its Growth (C). Analysts rate it Buy with a $25.25 price target (+11.5% upside).

Strongest
ValuationA-
Weakest
GrowthC
All factor grades
  • ValuationA-
  • ProfitabilityB+
  • MomentumB+
  • Financial StrengthC+
  • ForecastC+
  • GrowthC
  • Piotroski5/9
Score methodology
Press Releases

Contact

KIDS stock: frequently asked questions

What is KIDS's ST Score?

OrthoPediatrics Corp. (KIDS) has an ST Score of 59.1 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is KIDS a buy, hold, or sell?

Analysts rate KIDS a Buy, with a price target of $25.25 (+11.5% vs the current price). Our ST Score grades it B- (59.1/100). The ST Score is a data-driven signal, not a recommendation.

What are KIDS's factor grades?

Valuation A-, Profitability B+, Financial Strength C+, Momentum B+, Growth C, Forecast C+.

What is KIDS's valuation grade?

OrthoPediatrics Corp. (KIDS) earns a valuation grade of A-, measured against Medical - Devices peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is KIDS's growth grade?

OrthoPediatrics Corp. (KIDS) earns a growth grade of C, measured against Medical - Devices peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is KIDS's profitability grade?

OrthoPediatrics Corp. (KIDS) earns a profitability grade of B+, measured against Medical - Devices peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is KIDS's financial strength grade?

OrthoPediatrics Corp. (KIDS) earns a financial strength grade of C+, measured against Medical - Devices peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is the analyst price target for KIDS?

The average analyst price target for OrthoPediatrics Corp. (KIDS) is $25.25 from 13 analysts, which is +11.5% versus the recent price of $22.64.

What is KIDS's Piotroski score?

OrthoPediatrics Corp. (KIDS) has a Piotroski F-Score of 5 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.